Year: 2025

HighlightsThe Hearing division delivered 7% organic revenue growth driven by the continued strong performance of ReSound Vivia, enabling broad-based market share gains. The divisional profit margin ended at 34%, driven by positive operating leverage, but partly offset by negative country mix The Enterprise division continued to experience positive sell-out growth outside of Europe, driven by strong channel execution and market leading innovation, while Europe continued to be challenged due to market uncertainty. Reflecting continued inventory reductions in North America, organic revenue growth ended at -4%. The divisional profit margin ended at 34%, as a result of negative operating leverage and tariff headwinds offset by price increases and cost focus The Gaming division continued to perform well and take share in a challenged market,...

COMMENTARY FROM MANAGEMENT Merko Ehitus generated revenue of EUR 74 million in the third quarter of 2025 and EUR 242 million in the first 9 months of the year. Net profit for Q3 amounted to EUR 15.0 million, while net profit for the 9-month period was EUR 36.7 million. So far this year, Merko has handed over 55% more apartments and commercial premises to buyers than in the first nine months of last year. According to the management of Merko Ehitus, the third quarter, some of the most significant construction projects in recent times and the largest in Merko’s history were completed – the Arter quarter together with the interior works of the Swedbank headquarters in Tallinn and the Pabradė defence campus in Lithuania. As a result, group is returning to its more usual revenue structure. During the first nine months of this year, the share...

Press release Communiqué de presse PersberichtSyensqo third quarter 2025 results Underlying EBITDA of €326 million, resilient margin performance; Strong cash generation with FCF of €250 million in Q3; Agreement to divest Oil & Gas, advancing pure play specialty strategy Brussels, November 6, 2025, 7.00am CET Q3 2025 HighlightsNet sales of €1.52 billion impacted by unfavourable year-on-year foreign exchange movements (-5%), lower volumes (-1%); Strong year-on-year growth in Technology Solutions; Gross profit of €484 million decreased by 15% year-on-year, primarily driven by lower volumes and unfavorable foreign exchange movements, resulting in gross margin of 31.9%; On a sequential basis, gross margin was unchanged; Underlying EBITDA of €326 million decreased by 10% year-on-year organically, primarily due to lower underlying...

Compared to the optimistic estimates at the beginning of the year, the economic growth forecast for 2025 has become increasingly modest. Estonia’s economic growth continues at a slow pace, with the latest forecasts estimating annual growth at 0.6%. The construction market shows signs of stabilisation, but the sector’s recovery remains very slow and uneven.The Buildings segment accounts for 80% of the Group’s total revenue, and there has been no significant change in the revenue distribution between segments compared to the same period last year. The decrease in revenue compared to the same period in 2024 was primarily affected by an approximately 21% decline in the volume of the Buildings segment. Revenue in the Infrastructure segment remained essentially at the same level. During the reporting period, the Group signed a substantial volume...

Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024 RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting sustained growth in patients and prescribers Joenja® (leniolisib) third quarter revenue increased by 35% to US$15.1 million, compared to third quarter 2024, reflecting strong growth in patients on therapy FDA granted priority review of sNDA for leniolisib for children aged 4 to 11 years with APDS with decision expected by January 2026 Third quarter operating profit increased by 285% to US$15.8 million, compared to US$4.1 million in the third quarter 2024 Generated US$32.0 million in cash flow from operations during the quarter and US$44.0 million year to date 2025 total revenue guidance raised to US$365 – US$375 million,...

Oslo, 6 November 2025 – DNO ASA, the Norwegian oil and gas operator, today reported record revenue of USD 547 million and operating profit of USD 222 million in the third quarter of 2025, both more than double the previous quarter’s figures. Net production grew to 115,400 barrels of oil equivalent per day (boepd), with 77,300 boepd from the North Sea, including the acquired Sval Energi AS assets, 34,900 boepd from the Kurdistan region of Iraq and 3,100 boepd from West Africa. DNO expects to further increase net production during the fourth quarter and exit the year with the North Sea approaching 90,000 boepd and Kurdistan approaching 60,000 boepd on gross operated Tawke license production of 80,000 boepd. Contributing to the increase in Norway, Andvare (32 percent) was put on production in late September and Verdande (14 percent) is expected...

Lochem, 6 November 2025 PRESS RELEASE Trading Update Q3 2025: Solid volume growth and continued strong profitability Pieter Wolleswinkel, CEO ForFarmers: “We look back on a very strong quarter in which we continue the good performance of the past two years. Thanks to our customer-oriented approach and the commitment of our employees, we have once again achieved growth in market share. Recent acquisitions have also contributed to this. Despite the effects of the buyout schemes that are now clearly visible, our compound feed volumes in the Netherlands remain at a good level. Furthermore, the transfer of Beukelaar Diervoeders was completed at the beginning of November, further optimizing our position and capacity utilization in the broiler sector. The strong results continued in both the United Kingdom and Poland, with which our markets outside...

DEMIRE reports expected decline in earnings as a result of property sales in the first three quarters of 2025Rental income fell to EUR 41.4 million (previous year: EUR 50.6 million) as a result of the smaller portfolio size. FFO I (after tax, before minorities and interests on shareholder loans) decreased to EUR 8.3 million (previous year: EUR 23.0 million). Guidance for 2025 confirmed: rental income between EUR 52.0 million and EUR 54.0 million; FFO I (after taxes, before minority interests and interests on shareholder loans) between EUR 5.0 million and EUR 7.0 million.Langen, 6 November 2025.  DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) recorded the expected decline in earnings in the first nine months of 2025. This is in line with the forecast and is mainly attributable to the targeted reduction of the real...

Bíldudalur, 6 November 2025 Attached is the presentation for the third quarter 2025 results. The Group’s CEO Bjørn Hembre and Interim CFO Edvin Aspli will be presenting the third quarter results today at 09:00 Icelandic time (10:00 CET) via a Teams webinar. To register, please email edvinaspli@arnarlax.is. A link will be distributed before the webinar begins. For further information, please contact:CEO Bjørn HembreTel: +354 620 1936Email: bjorn@arnarlax.is Interim CFO Edvin AspliTel: +354 835 7800Email: edvinaspli@arnarlax.is Icelandic Salmon is dual-listed on the stock exchange market, both at the Euronext Growth in Oslo and NASDAQ First North in Reykjavík. The Group is the 100% owner of Arnarlax ehf, a farming company in Iceland with head office in Bíldudalur. The Group is fully integrated, from egg to the fish delivered to customers...

Record-high harvest volume in the quarter, reduced cost level and continued strong demand, sets the stage for improved performance going forward, but the financial result in the third quarter was as expected marked by low market prices for salmon. Operational EBIT for Norway was NOK 858 million in Q3 2025. The harvest volume was 89,400 tons, and operational EBIT per kg was NOK 9.6. For the group, operational EBIT was NOK 711 million in Q3 2025. The harvest volume was 93,200 tons, and operational EBIT per kg was NOK 7.6. The share of superior quality is back to normal levels, and there are still strong biological performances, particularly in Northern Norway, with positive cost development during the period. Strong results from Sales and Industry, driven by positive contributions from contracts and flexibility in harvesting and processing...